Navigation Links
Cure for Hepatitis B

An Indian medicinal plant may be one of the most effective ways of treating disorders caused by the Hepatitis B virus, according to new research. Clinical trials using a drug based on the Keezhanali plant were conducted at the University of Madras in South India and the Scottish Centre// for Infection in Glasgow.

The results are believed to be better than any drug so far used to treat Hepatitis B - which is more than 100 times more infectious than HIV. Researchers say Keezhanali - or Phyllanthus Amarus to use its botanical name - stopped the Hepatitis B virus from multiplying and cleared up symptoms within a month in 30% of all cases they studied.

Hepatitis B is common in Asia, particularly in the sub-continent and China, and traditional Indian medical practice has long-standing methods for its treatment.

Dr S Thiagrajan, who began the research nearly two decades ago, says "This plant has been used conventionally in folklore medicine as a paste for treating jaundice cases. At that point of time, we had Hepatitis B as an easier viral model for studying in the lab. That is why we took it up and we had good convincing evidence by in-vitro studies that this plant extract is able to inactivate the virus," he added.

According to Dr Thiagranjan, the new drug scores over the two main drugs used to treat the virus - Lamuvidime and Interferon - because it is highly affordable and does not have the usual side-effects such as aches and pains and hair loss.The new drug is expected to be put on the Indian market by early next year, after which it will move to pharmaceutical counters around the world.


'"/>




Page: 1

Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Hepatitis E virus made impotent
4. Sharing injection equipment spreads Hepatitis C
5. Lymphomas Link to Hepatitis C
6. Hepatitis shots is promising
7. Need for Hepatitis Booster Questioned
8. Good News for HIV Patients Also Suffering From Hepatitis C Virus
9. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
10. The Effectiveness Of Hepatitis B Vaccine Questioned
11. New Treatment for Chronic Hepatitis B
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2016)... , ... April 30, 2016 , ... “Aging well is a challenge for all of us, but there are things ... Parul T. Kohli . “Research is showing more and more that there are simple, yet ... and disability as we age.” Top priorities Dr. Kohli’s recommends for her patients include;, ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Footwear Foundation, the national charitable foundation serving the footwear industry, has broken all ... representing more than 130 companies across 23 states during the months of April ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... the heart of our nation’s productivity, stability, even security. Most importantly, employees are ... organizations. , Then why are American workers so unhappy? , Just under half ...
(Date:4/29/2016)... Fla. (PRWEB) , ... April 29, 2016 , ... ... Hospital surgeon reveals that infants born with severe congenital diaphragmatic hernia have better ... is born with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to ...
(Date:4/29/2016)... ... 29, 2016 , ... The Gluten-Free Certification Program (GFCP), in ... the launch of the GFCP Scoop in response to consumer demand ... the GFCP Scoop site is to keep the gluten-free community updated ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Italy , April 27, 2016 ... linear accelerator (MR-linac) platform will be the focal point ... meeting of the European Society for Radiotherapy & Oncology, ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and a ... physician to clearly see the patient,s anatomy in real ...
(Date:4/27/2016)... Shire plc (LSE: SHP, NASDAQ: ... Financial Officer, will present at the Deutsche Bank 41st Annual ... on Wednesday, May 04, 2016, 10:00 am EDT (15:00 BST). ... the Presentations and Webcasts section of Shire,s Investor website at ... be available on this same website for approximately 90 days. ...
(Date:4/27/2016)... April 27, 2016 At the ... launch of a Phase 2 clinical study of its ... patients undergoing cochlear implantation (CI) surgery. This large, placebo-controlled, ... Germany and France ... ear at the time of surgery. "Despite advances in ...
Breaking Medicine Technology: